A
ADC Therapeutics
Biotech & Life Sciences · Epalinges, Switzerland · Founded 2011 · IPO 2020 Unicorn
Investors
6 investors on ADC Therapeutics's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where ADC Therapeutics has talent and traffic
(1 of 272 staff)
team presence
across markets
Patent intelligence
$61M patent portfolio · 36 active families
Where ADC Therapeutics concentrates vs peers
Each axis is a top-10 topic across ADC Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about ADC Therapeutics
An AI-synthesized read of the highest-engagement posts about ADC Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ADC Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.